2024-05-08 16:22:18
Japanese newspaper The Mainichi reported that scientists at the Kitano Medical Research Institute plan to begin testing a drug to treat tooth aplasia next September. “In practice, it will be possible to use this drug on a large scale after six years.”
Dental aplasia causes a lack of teeth during the growth of the jaw bone at an early age, making it difficult to use and implant dentures. The new medicine will be able to replace non-developing or fallen teeth.
According to the newspaper, congenital hypodontia (loss of 6 or more teeth, known as oligodontia) is a hereditary condition that occurs in 1 percent of people.
According to the documents of the Japanese Institute, “Men between the ages of 30 and 65 years who do not suffer from obvious health problems and are missing one or more molars will be selected to test the innovative medicine, where the medicine will be injected intravenously.” Testing will continue until August 2025.
The inventors of the drug say that it “suppresses the activity of the USAG-1 protein, which prevents tooth growth.” Therefore, in the future, it will be possible to implant teeth not only in people who suffer from congenital diseases, but also in those who have lost their teeth due to decay or injury.”
It is worth noting that researchers tested the innovative drug on animals in 2018, and succeeded in growing teeth in mice and rodents.
Suggest a correction
2024-05-08 16:22:18